September 2026
1. ASHER E, Taha L, Karmi M, Brin A, et al
   Immature Platelet Fraction as an Independent Marker of Adverse Outcomes in an Intensive Cardiovascular Care Unit.
   Thromb Haemost. 2026 Sep 11. doi: 10.1055/a-2944-1196.
   

   >> Share

   
   
2. ASHER E, Taha L, Karmi M, Sabouret P, et al
   Association of Admission Immature Platelet Fraction with Long-Term Mortality Following Primary Percutaneous Coronary Intervention for STEMI.
   Thromb Haemost. 2026 Sep 7. doi: 10.1055/a-2945-5355.
   

   >> Share

   
   
3. GALUSKO V, Panoulas V, Gorog DA, Vandenbriele C, et al
   Stroke in Mechanical Circulatory Supported Cardiogenic Shock.
   Thromb Haemost. 2026;126:883-896.
   

   >> Share

   
   August 2026
4. NA K, Qiu M, Zhang T, Li Y, et al
   Ticagrelor versus Clopidogrel in Acute Coronary Syndrome Patients with High Ischemic and Bleeding Risk after Drug-eluting Stent Implantation.
   Thromb Haemost. 2026 Aug 11. doi: 10.1055/a-2922-8191.
   

   >> Share

   
   July 2026
5. VON HUNDELSHAUSEN P, Siess W, Weber C
   Bruton Tyrosine Kinase as Therapeutic Target in Cardiovascular Diseases-Executive Summary.
   Thromb Haemost. 2026 Jul 8. doi: 10.1055/a-2886-8670.
   

   >> Share

   
   
6. JMEL MA, Bialek EL, Sels M, Kotsyfakis M, et al
   Beyond the Bite: Tick Salivary Proteins Targeting Hemostasis and Inflammation; Implications for Cardiovascular Disease.
   Thromb Haemost. 2026 Jul 8. doi: 10.1055/a-2899-3775.
   

   >> Share

   
   June 2026
7. LAHU D, Simonetti F, Koka E, Mayer K, et al
   Sex-Dependent Platelet Inhibition with Prasugrel and Ticagrelor after Percutaneous Coronary Intervention in Acute Coronary Syndromes.
   Thromb Haemost. 2026 Jun 5. doi: 10.1055/a-2888-9768.
   

   >> Share

   
   May 2026
8. MAURO MS, Finocchiaro S, Calderone D, Laudani C, et al
   Bleeding and Thrombotic Trade-off in Dual-Risk Patients Undergoing Percutaneous Coronary Intervention.
   Thromb Haemost. 2026 May 29. doi: 10.1055/a-2862-6563.
   

   >> Share

   
   April 2026
9. SCHOENHERR A, Ji Y, Khoukaz H, Lyu Z, et al
   Plasminogen Activator Inhibitor-1 Controls Mitochondrial Oxidative Stress in Vascular Smooth Muscle Cells and Coronary Arteries.
   Thromb Haemost. 2026 Apr 24. doi: 10.1055/a-2852-0770.
   

   >> Share

   
   March 2026
10. UJUETA F, Bikdeli B
    Persistent Left Ventricular Thrombus After Myocardial Infarction: The Potential Role of Inherited Thrombophilia.
    Thromb Haemost. 2026 Mar 16. doi: 10.1055/a-2827-2069.
    

    >> Share

    
    
11. KURASZ A, Abohashem S, El-Bouri WK, Ortega-Martorell S, et al
    Air, Noise, and Light Pollution and Thromboembolic Cardiovascular Complications: A TH Scientific Statement.
    Thromb Haemost. 2026 Mar 13. doi: 10.1055/a-2820-4197.
    

    >> Share

    
    February 2026
12. MROZ K, Paszek E, Wypasek E, Undas A, et al
    Inherited Thrombophilia as a Risk Factor for Persistent Left Ventricular Thrombus Following Acute Myocardial Infarction.
    Thromb Haemost. 2026 Feb 9. doi: 10.1055/a-2794-5001.
    

    >> Share

    
    January 2026
13. HONDA S, Cho KH, Lee SY, Takegami M, et al
    Prognostic Value of BARC-defined Bleeding in East Asian Acute Myocardial Infarction Patients: Evidence from Multicentre Registries in Korea and Japan.
    Thromb Haemost. 2026 Jan 6. doi: 10.1055/a-2773-5644.
    

    >> Share

    
    December 2025
14. CAMERA M, Brambilla M, Cosentino N, Becchetti A, et al
    Tissue factor, a membrane-associated marker of platelet activation, predicts 5-year cardiovascular mortality in coronary artery disease patients.
    Thromb Haemost. 2025 Dec 15. doi: 10.1055/a-2771-2148.
    

    >> Share

    
    November 2025
15. VICHOVA T, Motovska Z
    The Role of Oxidative Stress and MicroRNAs in Platelet Activation and the Efficacy of Antiplatelet Therapy in Acute Myocardial Infarction.
    Thromb Haemost. 2025 Nov 27. doi: 10.1055/a-2741-4754.
    

    >> Share

    
    
16. FUJIYAMA A, Arima Y, Inoue R, Kuyama N, et al
    Profiling Initial Thrombin Generation in Cardiovascular Disease using a High Sensitivity Coagulation Assay.
    Thromb Haemost. 2025 Nov 21. doi: 10.1055/a-2751-8379.
    

    >> Share

    
    October 2025
17. VAN ZELM AMH, Fiolet AT, Hinchliffe RJ, Jansen S, et al
    Current evidence and future directions for colchicine in the prevention of atherosclerotic cardiovascular disease.
    Thromb Haemost. 2025 Oct 23. doi: 10.1055/a-2724-4543.
    

    >> Share

    
    
18. ORTEGA-PAZ L, Ueki Y, Laudani C, Losdat S, et al
    Impact of PCSK9 inhibition on Platelet Reactivity in Patients with Atherosclerotic Cardiovascular Disease: A Pooled analysis of two Randomized Trials.
    Thromb Haemost. 2025 Oct 10. doi: 10.1055/a-2717-5994.
    

    >> Share

    
    September 2025
19. NIEZGODA P, Podhajski P, Kasprzak M, Baranska M, et al
    Methoxyflurane Instead of Morphine in Acute Coronary Syndrome Patients: Results of the Randomized Controlled METHANE-SIRIO 4 Study.
    Thromb Haemost. 2025 Sep 18. doi: 10.1055/a-2698-3958.
    

    >> Share

    
    
20. WU Y, Wang H, Wang Z, Hua C, et al
    Identifying Risk Factors for Left Ventricular Thrombus in Patients with Ischemic Left Ventricular Aneurysm Using Cardiac MRI.
    Thromb Haemost. 2025;125:908-915.
    

    >> Share

    
    July 2025
21. THYMIS J, Katogiannis K, Pavlidis G, Vlastos D, et al
    Association of Endothelial Glycocalyx Integrity with Left Ventricular Performance and Remodeling after Acute Myocardial Infarction: A 12-month Follow-up Study.
    Thromb Haemost. 2025 Jul 10. doi: 10.1055/a-2632-3249.
    

    >> Share

    
    May 2025
22. LI J, Chen R, Zhao X, Liu C, et al
    Circulating and Regional Matrix Gla Protein Indicating Plaque Calcification and Prognosis of Patients with ST-Segment Elevation Myocardial Infarction.
    Thromb Haemost. 2025 May 23. doi: 10.1055/a-2599-9386.
    

    >> Share

    
    April 2025
23. SPAGNOLO M, Capodanno D
    Factor XI Inhibitors for Myocardial Infarction: A Safer Path to Thrombotic Protection?
    Thromb Haemost. 2025 Apr 25. doi: 10.1055/a-2593-1763.
    

    >> Share

    
    
24. VALERIANI E, Sesso HD, Pastori D, Menichelli D, et al
    Age related clinical efficacy of aspirin for primary cardiovascular prevention: a systematic-review and meta-analysis.
    Thromb Haemost. 2025 Apr 11. doi: 10.1055/a-2580-6931.
    

    >> Share

    
    March 2025
25. GOROG DA, Jeong YH
    Factor XI Measurement in Acute Coronary Syndrome.
    Thromb Haemost. 2025 Mar 31. doi: 10.1055/a-2546-2581.
    

    >> Share

    
    February 2025
26. DUAN Y, Qiu M, Na K, Liu D, et al
    Inflammatory and Bleeding Risks on Clinical Outcomes in Acute Coronary Syndrome Patients Undergoing Percutaneous Coronary Intervention.
    Thromb Haemost. 2025 Feb 4. doi: 10.1055/a-2531-3268.
    

    >> Share

    
    
27. ZHENG YY, Wu TT, Hou XG, Yang Y, et al
    Low HDL Cholesterol is Associated with Reduced Bleeding Risk in Patients who Underwent PCI: Findings from the PRACTICE Study.
    Thromb Haemost. 2025;125:178-187.
    

    >> Share

    
    January 2025
28. SPAGNOLO M, Ammirabile N, Cutore L, Di Leo G, et al
    Changes in Coagulation Factor XI Activity Levels in Patients with ST-Segment Elevation Myocardial Infarction Undergoing Primary PCI.
    Thromb Haemost. 2025 Jan 27. doi: 10.1055/a-2525-4219.
    

    >> Share

    
    December 2024
29. JANG JY, Ga-In Y, Jongwha A, Bae JS, et al
    Optimal Long-term Antiplatelet Regimen for Patients with High Ischaemic and Bleeding Risks After Percutaneous Coronary Intervention.
    Thromb Haemost. 2024 Dec 10. doi: 10.1055/a-2499-5458.
    

    >> Share

    
    November 2024
30. SUAREZ A, Tobio-Parada U, Rodriguez-Carrio J, Martinez-Zapico A, et al
    Circulating levels of Low Density Granulocytes and cell-free DNA as predictors of cardiovascular disease and bone deterioration in SLE patients.
    Thromb Haemost. 2024 Nov 14. doi: 10.1055/a-2467-6826.
    

    >> Share

    
    
31. GU M, Xia N, Zhang S, Zhu X, et al
    Characterization of CD3+ T Lymphocytes in Human Coronary Thrombi with ST-segment Elevation Myocardial Infarction.
    Thromb Haemost. 2024 Nov 7. doi: 10.1055/a-2437-6111.
    

    >> Share

    
    October 2024
32. VAN DER SANGEN NMR, Azzahhafi J, Chan Pin Yin DRPP, Zaaijer LJG, et al
    Treatment Modifications in Acute Coronary Syndrome Patients Treated with Ticagrelor: Insights from the FORCE-ACS Registry.
    Thromb Haemost. 2024 Oct 29. doi: 10.1055/a-2421-8866.
    

    >> Share

    
    
33. GRAGNANO F, Angiolillo D
    Ticagrelor therapy modifications after acute coronary syndrome: An ever-evolving issue.
    Thromb Haemost. 2024 Oct 24. doi: 10.1055/a-2448-7029.
    

    >> Share

    
    
34. ASARE Y, Simsekyilmaz S, Kohncke J, Shagdarsuren G, et al
    Cardiac repair after myocardial infarction is controlled by a complement C5a receptor 1-driven signaling cascade.
    Thromb Haemost. 2024 Oct 4. doi: 10.1055/a-2434-4905.
    

    >> Share

    
    September 2024
35. GEISLER T
    Editorial : "Clinical impact of dyspnea after ticagrelor treatment and the effect of switching to clopidogrel in patients with myocardial infarction".
    Thromb Haemost. 2024 Sep 23. doi: 10.1055/a-2420-0381.
    

    >> Share

    
    August 2024
36. KONSTANTINIDES SV
    Shifting Priorities in the Prevention of Venous Thromboembolism: Time to Focus on Overall Cardiovascular Health.
    Thromb Haemost. 2024 Aug 12. doi: 10.1055/s-0044-1788926.
    

    >> Share

    
    June 2024
37. HRISTOV M, Weber C
    Monocyte subsets in cardiovascular disease: a biomarker perspective.
    Thromb Haemost. 2024 Jun 19. doi: 10.1055/a-2348-5697.
    

    >> Share

    
    
38. CATTANEO M, Squizzato A, Birocchi S, Podda GM, et al
    Guided Anti-P2Y12 Therapy in Patients Undergoing Percutaneous Coronary Intervention.
    Thromb Haemost. 2024;124:595-597.
    

    >> Share

    
    
39. UEKI Y, Haner JD, Losdat S, Gargiulo G, et al
    Effect of Alirocumab Added to High-Intensity Statin on Platelet Reactivity and Noncoding RNAs in Patients with AMI: A Substudy of the PACMAN-AMI Trial.
    Thromb Haemost. 2024;124:517-527.
    

    >> Share

    
    May 2024
40. BIROCCHI S, Rocchetti M, Minardi A, Podda GM, et al
    Guided Anti-P2Y12 Therapy in Patients Undergoing PCI: Three Systematic Reviews with Meta-analyses of Randomized Controlled Trials with Homogeneous Design.
    Thromb Haemost. 2024;124:482-496.
    

    >> Share

    
    April 2024
41. LIANG B, Zha L, Peng B, Chen Q, et al
    Association of Cardiovascular Health with the Incidence of Venous Thromboembolism: A Prospective Study of 275,149 Participants from the UK Biobank.
    Thromb Haemost. 2024 Apr 12. doi: 10.1055/a-2305-6631.
    

    >> Share

    
    
42. KIM SH, Shin S, Choo EH, Choi IJ, et al
    Clinical impact of dyspnoea after ticagrelor treatment and the effect of switching to clopidogrel in patients with myocardial infarction.
    Thromb Haemost. 2024 Apr 4. doi: 10.1055/a-2299-4537.
    

    >> Share

    
    March 2024
43. ORTEGA-PAZ L, Franchi F, Rollini F, Galli M, et al
    Switching from Dual Antiplatelet Therapy with Aspirin Plus a P2Y12 Inhibitor to Dual Pathway Inhibition with Aspirin Plus Vascular-Dose Rivaroxaban: The Switching Anti-Platelet and Anti-Coagulant Therapy (SWAP-AC) Study.
    Thromb Haemost. 2024;124:263-273.
    

    >> Share

    
    December 2023
44. YE Y, Hao Y, Zhao X, Liu J, et al
    Percutaneous coronary intervention in acute coronary syndrome with mild-to-moderate thrombocytopenia.
    Thromb Haemost. 2023 Dec 11. doi: 10.1055/a-2225-5263.
    

    >> Share

    
    

Free Medical Abstracts
Privacy Policy
Sponsors
Share